Number of Shares
1.64 Mil
Current Holdings Value*
$443.70 Mil
% of Portfolio
1.71%
Total Estimate Gain
$347.15 Mil
% of Total Estimate Gain
140.93%

T. Rowe Price Mid-Cap Growth Fund, Inc.'s Alnylam Pharmaceuticals Inc Holding Summary

As of 2025-03-31, T. Rowe Price Mid-Cap Growth Fund, Inc. held 1.64 Mil shares of Alnylam Pharmaceuticals Inc(ALNY), totaling $443.70 Mil. This investment constitutes 1.71% of their stock portfolio, and T. Rowe Price Mid-Cap Growth Fund, Inc. now holds 1.26% of the outstanding Alnylam Pharmaceuticals Inc(ALNY) stock.

The initial trade took place in 2019Q3. And since then T. Rowe Price Mid-Cap Growth Fund, Inc. has made 8 purchases of ALNY, at an average price of $118.93, for a total of 2.07 Mil shares. In addition, there have been 9 sales at an average price of $177.53 for 427,900.00 shares. Based on historical transaction data and ALNY's current price of $314.94, T. Rowe Price Mid-Cap Growth Fund, Inc.'s estimated gain on his ALNY holdings is $347.15 Mil, reflecting a 140.93% gain to date.

T. Rowe Price Mid-Cap Growth Fund, Inc. ALNY ($314.94) Holding Chart

T. Rowe Price Mid-Cap Growth Fund, Inc. ALNY ($314.94) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1